Home > Blog > Full service phase ii cancer trial

1 min read

Successful Full-Service, Randomized Pancreatic Cancer Phase II Trial

Success Stories Oncology Biologics Full-Service

Learn how Veristat’s multidisciplinary team was able to work with the sponsor to solve challenges across numerous areas of this full-service phase II cancer trial. Collaborative efforts led to the sponsor decided not to close the Phase II study upon the recommendation of the Safety Review Committee since the primary endpoint was met and there were no safety concerns.

A clinical-stage biopharmaceutical company approached Veristat in a multi-center, randomized Phase II study of a modified synthetic peptide in patients with exocrine pancreatic cancer. The study aimed to establish the efficacy and safety of combinations of the therapy in patients with stage IV exocrine pancreatic cancer. 

In this piece, learn how Veristat’s multidisciplinary team was able to work with the sponsor to solve challenges across numerous areas including: 
  • Slow recruitment
  • Data cleansing post-MSU
  • Multi-site location, process, and staffing
DOWNLOAD

 

Meet Veristat. Learn More.


 

2 min read

ASCO Annual Meeting

Apr 23, 2025  Veristat Events

Meet Veristat at the 2025 ASCO Annual Meeting 

Advancing Oncology Therapies for Patients in Need 

Veristat is proud to...

1 min read

OCT East Coast

Apr 9, 2025  Veristat Events

Meet Veristat at the 16th Annual Outsourcing in Clinical Trials East Coast 2025

Veristat is excited to participate in...